Ethane

Ethane

SCHEMBL5755629

CC.[Cl-].[Ni+]P(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Ethane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.33
CYP3A4 P08684 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
ESR1 P03372 4/20 0.37
ESR2 Q92731 4/20 0.37
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
ALOX12 P18054 1/20 0.33
DRD1 P21728 2/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propane SCHEMBL5194963 0.89 TDP1 (0.41) CYP3A4TDP1ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL67801 0.81 CYP3A4 (0.35) CYP3A4TDP1ESR1ESR2
Hydrochloric Acid SCHEMBL1275643 0.81 CYP3A4 (0.35) CYP3A4TDP1ESR1ESR2
Hydrochloric Acid SCHEMBL8797597 0.78 CYP3A4 (0.32) CYP3A4TDP1
Ethane SCHEMBL10788468 0.71 TDP1 (0.53) CYP3A4TDP1ESR1ESR2KDM4E
Ethane SCHEMBL27526681 0.71 TDP1 (0.86) CYP3A4TDP1ESR1ESR2KDM4E
Ethane SCHEMBL5591026 0.71 CYP3A4 (0.45) CYP3A4TDP1ESR1ESR2KDM4E
Ethane SCHEMBL3943018 0.71 CYP3A4 (0.45) CYP3A4TDP1ESR1ESR2KDM4E
Ethane SCHEMBL3946960 0.71 CYP3A4 (0.53) CYP3A4TDP1ESR1ESR2KDM4E
Ethane SCHEMBL27638605 0.69 TDP1 (0.80) CYP3A4TDP1ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115784826-A Method for nickel-catalyzed double-carbon functionalization reaction of non-activated olefin 南京师范大学 2023-03-14 CN claimed
CN-115651017-A Method for selectively preparing benzyl or alkyl phosphine oxide compound based on benzyl thioether derivative 中南大学 2023-01-31 CN claimed
CN-110511188-B Preparation method of 2-imino dihydro quinazolinone compound 烟台大学 2022-09-20 CN claimed
CN-114956979-A Catalyst system for synthesizing phenylacetic acid from toluene 中国科学技术大学 2022-08-30 CN claimed
CN-114605306-B Method for synthesizing organic sulfur compound based on alkyl xanthate and application thereof 南京师范大学 2022-07-29 CN claimed
CN-111057053-B Preparation method of zolpidem 复旦大学 2022-07-08 CN claimed
CN-112592301-B Photocatalysis synthesis method of aryl thioether and derivatives thereof 浙江工业大学 2022-06-17 CN claimed
CN-114605306-A Method for synthesizing organic sulfur compound based on alkyl xanthate and application thereof 南京师范大学 2022-06-10 CN claimed
CN-114573412-A Preparation method of benzoperylene 杭州凯名庞德生物科技有限公司 2022-06-03 CN claimed
CN-114149405-A Method for synthesizing aromatic thioether through aromatic exchange bimetallic catalysis and application 中国科学院大学 2022-03-08 CN claimed
CN-112939728-A Preparation method of frainer intermediate 1, 3-dichloro-alpha- (trifluoromethyl) styrene 石家庄手性化学有限公司 2021-06-11 CN claimed
CN-112778127-A Preparation method of flurbiprofen 北京澳合药物研究院有限公司 2021-05-11 CN claimed
CN-112079865-A Phosphine nitrogen ligand with multiple chiral centers and synthetic method and application thereof 中国科学院上海有机化学研究所 2020-12-15 CN claimed
CN-108658929-B Preparation method of high-purity 2- (4-fluorophenyl) thiophene 宁波人健化学制药有限公司 2020-11-17 CN claimed
CN-111100536-A Anti-aging ultraviolet curing composite conductive coating and preparation method thereof 宁波其兰文化发展有限公司 2020-05-05 CN claimed
CN-111057053-A Preparation method of zolpidem 复旦大学 2020-04-24 CN claimed
CN-110511188-A A kind of preparation method of 2- imino group dihydro quianzolinones UNIV YANTAI 2019-11-29 CN claimed
EP-1648884-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Pharmacia Italia S.p.A. (IT) 2006-04-26 EP claimed
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US claimed
WO-2005005414-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PHARMACIA ITALIA S.P.A. (IT) 2005-01-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 ACHE 2188/4885CYP3A4 1408/4885TDP1 1397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.